Related Experiment Videos
DNA topoisomerase II poisons and inhibitors
G Capranico1, G Giaccone, F Zunino
1Istituto Nazionale per lo Studio e la Cura dei Tumori, Milano, Italy.
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Improved apoptotic cell death in drug-resistant non-small-cell lung cancer cells by tumor necrosis factor-related apoptosis-inducing ligand-based treatment.
The Journal of pharmacology and experimental therapeutics·2013
Tyrosyl-DNA phosphodiesterase 1 targeting for modulation of camptothecin-based treatment.
Current medicinal chemistry·2010
ABC transporters as potential targets for modulation of drug resistance.
Mini reviews in medicinal chemistry·2009
Small molecules targeting p53 to improve antitumor therapy.
Mini reviews in medicinal chemistry·2008
DNA topoisomerase II structures and anthracycline activity: insights into ternary complex formation.
Current pharmaceutical design·2007
Zerumbone combined with antimicrobial photodynamic inactivation reduces growth of Candida albicans biofilms and modulates virulence gene expression.
Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology·2026
Inhibiting glioma cell invasion by sequential photo-sonodynamic therapy.
Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology·2026
Vismodegib-loaded ufasomes inhaler for treatment of non-small cell lung cancer.
Naunyn-Schmiedeberg's archives of pharmacology·2026
A 177Lu-Labeled Circular Bivalent Aptamer for PTK7-Targeting Radionuclide Therapy in Ovarian Cancer and Orthotopic Hepatoblastoma.
Journal of medicinal chemistry·2026
Small-Molecule Activators of PRMT1: Discovery, SAR Analyses, and Proapoptotic Effects in Pancreatic Cancer Cells.
Journal of medicinal chemistry·2026
Discovery of Highly Efficacious CRBN-Based KRAS Degraders Targeting Cancers with KRAS G12D and G12V Mutations.
Journal of medicinal chemistry·2026